GlycoMimetics Inc (GLYC)
0.3141
-0.01
(-1.84%)
USD |
NASDAQ |
Nov 22, 15:09
GlycoMimetics Shareholders Equity (Quarterly): 11.38M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 11.38M |
| June 30, 2024 | 20.06M |
| March 31, 2024 | 28.91M |
| December 31, 2023 | 38.41M |
| September 30, 2023 | 46.55M |
| June 30, 2023 | 54.80M |
| March 31, 2023 | 62.18M |
| December 31, 2022 | 42.93M |
| September 30, 2022 | 48.12M |
| June 30, 2022 | 55.73M |
| March 31, 2022 | 68.03M |
| December 31, 2021 | 81.60M |
| September 30, 2021 | 96.57M |
| June 30, 2021 | 112.29M |
| March 31, 2021 | 125.12M |
| December 31, 2020 | 128.22M |
| September 30, 2020 | 138.27M |
| June 30, 2020 | 145.75M |
| March 31, 2020 | 148.49M |
| December 31, 2019 | 154.20M |
| September 30, 2019 | 167.08M |
| June 30, 2019 | 178.56M |
| March 31, 2019 | 192.79M |
| December 31, 2018 | 205.46M |
| Date | Value |
|---|---|
| September 30, 2018 | 218.10M |
| June 30, 2018 | 227.99M |
| March 31, 2018 | 238.04M |
| December 31, 2017 | 119.70M |
| September 30, 2017 | 108.56M |
| June 30, 2017 | 115.43M |
| March 31, 2017 | 31.89M |
| December 31, 2016 | 35.30M |
| September 30, 2016 | 41.75M |
| June 30, 2016 | 48.88M |
| March 31, 2016 | 34.77M |
| December 31, 2015 | 40.47M |
| September 30, 2015 | 48.70M |
| June 30, 2015 | 55.22M |
| March 31, 2015 | 44.36M |
| December 31, 2014 | 50.80M |
| September 30, 2014 | 57.71M |
| June 30, 2014 | 63.88M |
| March 31, 2014 | 55.35M |
| December 31, 2013 | 2.907M |
| September 30, 2013 | 6.515M |
| June 30, 2013 | 9.738M |
| December 31, 2012 | 12.53M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
11.38M
Minimum
Sep 2024
154.20M
Maximum
Dec 2019
80.38M
Average
65.11M
Median
Shareholders Equity (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 5.413B |
| Arbutus Biopharma Corp | 106.89M |
| Revance Therapeutics Inc | -163.03M |
| FibroGen Inc | -243.67M |
| Cidara Therapeutics Inc | 115.63M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 15.70M |
| Total Liabilities (Quarterly) | 4.322M |